|
Supplier News Breaks Archives AstraZeneca plans to acquire specialty pharmaceutical manufacturer Novexel in a deal worth up to $505 million. Novartis stands to gain exclusive global rights to heart failure drug relaxin through a deal to acquire U.S. biopharmaceutical firm Corthera Inc. Sanofi-aventis has inked an agreement to buy Chattem Inc. for $1.9 billion, a deal that the drug makers say would create the world's fifth-largest consumer health care company.
|
